Talengen Institute of Life Sciences, Shenzhen, P.R. China.
2 clinical trials · Sponsor
◉ Watch Talengen Institute of Life Sciences, Shenzhen, P.R. China.
| Record | Firm | Date |
|---|---|---|
| TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis (NCT06726577) | Talengen Institute of Life Sciences, Shenzhen, P.R. China. | 2026-05-10 |
| TP03HN106 in Patients With Critical Limb Ischemia (NCT06482892) | Talengen Institute of Life Sciences, Shenzhen, P.R. China. | 2024-07-18 |
Track Talengen Institute of Life Sciences, Shenzhen, P.R. China. automatically
Every clearance here is in the API, with alerts when new ones post.